RPS Group (RPS) Receives Outperform Rating from Royal Bank of Canada

Share on StockTwits

Royal Bank of Canada reiterated their outperform rating on shares of RPS Group (LON:RPS) in a research report sent to investors on Thursday morning.

A number of other research analysts have also weighed in on RPS. Peel Hunt restated an under review rating on shares of RPS Group in a report on Thursday, October 25th. Liberum Capital decreased their price objective on RPS Group from GBX 310 ($4.05) to GBX 260 ($3.40) and set a buy rating on the stock in a report on Thursday, October 25th.

Shares of LON:RPS traded down GBX 6 ($0.08) during midday trading on Thursday, reaching GBX 148.40 ($1.94). 716,609 shares of the company’s stock traded hands, compared to its average volume of 457,098. RPS Group has a 1 year low of GBX 225.36 ($2.94) and a 1 year high of GBX 307.50 ($4.02).

In other news, insider Allison Bainbridge acquired 16,400 shares of the firm’s stock in a transaction on Tuesday, October 30th. The shares were bought at an average price of GBX 161 ($2.10) per share, for a total transaction of £26,404 ($34,501.50). Also, insider John Douglas acquired 207,348 shares of the firm’s stock in a transaction on Thursday, October 25th. The stock was purchased at an average price of GBX 158 ($2.06) per share, for a total transaction of £327,609.84 ($428,080.28).

About RPS Group

RPS Group plc, a consultancy company, provides advice on the development and management of the built and natural environment; planning and development of strategic infrastructure; and evaluation and development of energy, water, and other resources. The company operates through Built and Natural Environment, Energy, and Australia Asia Pacific segments.

Further Reading: Marijuana Stocks Investing Considerations

Receive News & Ratings for RPS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RPS Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Equinix Inc  CEO Charles J. Meyers Sells 5,648 Shares
Equinix Inc CEO Charles J. Meyers Sells 5,648 Shares
United Therapeutics Co.  CEO Martine A. Rothblatt Sells 14,108 Shares
United Therapeutics Co. CEO Martine A. Rothblatt Sells 14,108 Shares
Fiserv Inc  Shares Bought by BTIM Corp.
Fiserv Inc Shares Bought by BTIM Corp.
BLB&B Advisors LLC Boosts Stake in iShares Core S&P Small-Cap ETF
BLB&B Advisors LLC Boosts Stake in iShares Core S&P Small-Cap ETF
D. R. Horton Inc  Shares Sold by Boston Advisors LLC
D. R. Horton Inc Shares Sold by Boston Advisors LLC
UrtheCast  Stock Price Down 10%
UrtheCast Stock Price Down 10%


Leave a Reply

© 2006-2019 Ticker Report